Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
Clinical trial NCT07469800 · RECRUITING
Trial details
- NCT number
- NCT07469800
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2026-08-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.